JaxBio

At JaxBio, we are revolutionising the way cancer is diagnosed and managed by making cancer detection simpler, quicker, and more precise, and were doing that through our innovative blood test technology. Our unique blood test offers advantages over traditional methods and traditional liquid biopsies. Based on its high sensitivity together with low cost and simplicity, we can deliver results faster with improved accuracy. By improving screening and early detection capabilities for cancer, healthcare providers and patients can now make better informed decisions sooner when time is of the essence. We use novel artificial intelligence (AI) algorithms to identify sets of...

Health diagnostics,diagnostics test,cancer,cancer diagnostics,early cancer detection,disease monitoring,artificial intelligence in healthcare,precision medicine,healthcare innovation,blood test,dna medical kit,lung cancer,haematological malignancies,lymphoma,multiple myeloma,biomarkers,liquid biopsy,cell-free dna,and personalised medicine

Jaxbio operates in the Medical and diagnostic laboratories industry.

Jaxbio's revenue is 11m - 100m

Jaxbio has 11 - 50 employees.